Your browser doesn't support javascript.
loading
Engineered AAV8 capsid acquires heparin and AVB sepharose binding capacity but has altered in vivo transduction efficiency.
van Lieshout, Laura P; Stegelmeier, Ashley A; Rindler, Tara N; Lawder, John J; Sorensen, Debra L; Frost, Kathy L; Booth, Stephanie A; Bridges, James P; Wootton, Sarah K.
Afiliação
  • van Lieshout LP; Department of Pathobiology, University of Guelph, Guelph, ON, Canada.
  • Stegelmeier AA; Department of Pathobiology, University of Guelph, Guelph, ON, Canada.
  • Rindler TN; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Lawder JJ; Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Sorensen DL; Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Frost KL; Molecular Pathobiology, National Microbiology Laboratory NML, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Booth SA; Molecular Pathobiology, National Microbiology Laboratory NML, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Bridges JP; Molecular Pathobiology, National Microbiology Laboratory NML, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Wootton SK; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
Gene Ther ; 30(3-4): 236-244, 2023 04.
Article em En | MEDLINE | ID: mdl-33028973

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heparina / Capsídeo Idioma: En Revista: Gene Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heparina / Capsídeo Idioma: En Revista: Gene Ther Ano de publicação: 2023 Tipo de documento: Article